The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 20 - Manufacture of chemicals and chemical products 20 - Manufacture of chemicals and chemical products
12,000 jobs Number of planned job losses
Announcement Date
29 November 2018
Employment effect (start)
30 November 2018
Foreseen end date
1 January 2021
Description
The German chemicals and pharmaceuticals group Bayer has announced a reorganisation to achieve greater efficiency across its supporting functions and services, that will lead to cut 12,000 positions on a total workforce of 118,200 employees worldwide by the end of 2021, a significant number of them in Germany. Taking into account the 'synergies expected from the acquisition of Monsanto', stated the company, 'Bayer anticipates annual contributions of €2.6 billion from 2022 on as a result of its planned efficiency and structural measures'.
Details about the job cuts and countries affected 'will be worked out in the months ahead', according to the company. However, Bayer has already announced that the planned reduction of around 12,000 jobs is accounted for by the various measures as follows: at Pharmaceuticals, approximately 900 jobs in R&D and around 350 positions in connection with the factor VIII facility in Wuppertal (Germany); roughly 1,100 jobs associated with the reorganization at Consumer Health; around 4,100 positions at Crop Science as the result of integrating the acquired agriculture business; and a further 5,500 to 6,000 jobs in the corporate functions, supporting functions, business services and country platforms. 'These changes are necessary and lay the foundation for Bayer to enhance its performance and agility. With these measures, we aim to take full advantage of the growth potential for our businesses,' said the Chairman of the Board of Management of Bayer AG. He also commented that 'as in the past', the company 'will implement the planned measures in a fair and responsible way'.
Sources
Citation
Eurofound (2018), Bayer, Internal restructuring in World, factsheet number 95957, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/95957.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...